Clifford Rosen, MD
Maine Medical Center Research Institute
81 Research Drive
Scarborough ME, 04074
Phone: (207) 396-8228
Fax: (207) 396-8174
Dr. Clifford J. Rosen, M.D. is the Director of Clinical and Translational Research and a Senior Scientist at Maine Medical Center's Research Institute. His other current positions include Adjunct Staff Scientist at the Jackson Laboratory, and Professor of Medicine at Tufts University School of Medicine. Dr. Rosen is the founder and Former Director of the Maine Center for Osteoporosis Research and Education. He was the first Editor-in-Chief of the Journal of Clinical Densitometry, is the current Editor-in-Chief of The Primer in Metabolic Bone Diseases, and just began a term as Associate Editor for JCEM. His publications include more than 300 peer-reviewed manuscripts, covering both clinical and basic bone biology.
Dr. Rosen has overseen numerous phase II and III clinical trials, funded both privately and through the NIH. He is a member of the FDA Advisory Panel on Endocrinologic and Metabolic Drugs and a former chairperson of that committee. He was Permanent Chair of the NIH Review Panel for Skeletal Biology and Bone Diseases for 2002-2004, and is currently a member of the NIAMS Scientific Advisory Board. He served as president of the American Society for Bone and Mineral Research in 2002-2003, and was recently honored to present the Louis V. Avioli Memorial Lecture, "Bone Marrow Fat: Neighbor or Nemesis", at the 30th Annual ASBMR Official Scientific Meeting in Montreal, Canada. Dr. Rosen's research interests include the genetic regulation of insulin-like growth factor relative to skeletal metabolism, PTH as an anabolic therapy, and the relationship between marrow adipogenesis and osteoblastogenesis.
Director of Clinical and Translational Research, Maine Medical Center
Senior Scientist, Maine Medical Center Research Institute
Adjunct Staff Scientist, The Jackson Laboratory, Bar Harbor, ME
Professor of Medicine, Tufts University School of Medicine, Boston, MA
NIAMS Scientific Advisory Board
FDA Advisory Board on Endocrinologic and Metabolic Drugs